Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Hoher Wachstum
Der Umsatz des Unternehmens ist in den letzten 3 Jahren stetig gewachsen und beträgt im Durchschnitt 18.38% im Jahr.
Angemessen bewertet
Die aktuelle PE1 des Unternehmens liegt bei 38.602, im mittleren 3-Jahres-Perzentilbereich.
Institutionelle Verkäufe
Die neuesten institutionellen Bestände sind 88.51M Aktien, was einen Rückgang von 26.54% im Vergleich zum Vorquartal darstellt.
Gehalten von John Hussman
Star-Investor John Hussman1 hält 140.11K2 Aktien dieses Unternehmens.
Niedrigere Marktaktivität
Das Unternehmen hat weniger Investoreninteresse, mit einem 20-Tage-Umsatzverhältnis von -0.26.